1-10 of 10
Fatima De la Cruz Vicente
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance ?

Ana Marin Niebla, Mariana Bastos-Oreiro, Amanda Isabel Perez, Alba Cabirta Touzón, Fatima De la Cruz Vicente, Marta Canelo, Ana Jiménez Ubieto, Sonia González De Villambrosia, Ana Muntañola, Hugo Daniel Luzardo Henríquez, Eduardo Rios Herranz, Beatriz De La Cruz, Raul Cordoba, Ana Saus Carreres, Alejandro Martín García-Sancho, Ana Garcia Noblejas, Carlos Grande, Pablo Prieto Martinez, Concepción Nicolás, Antonio Gutierrez, Jose-Angel Hernandez Rivas, Blanca Sánchez-González, Rosalia Alonso Trillo, Eva Donato, Paola Villafuerte Gutiérrez, Daniel García Belmonte, Silvia Rocio Verdesoto Cozzarelli, Sandra Suarez Ordoñez, Emilia Pardal De La Mano, Lucia Villalon Blanco, Eva Gine, Juan-Manuel Sancho, Alberto Lopez Garcia, Alicia Roldán-Pérez, Pilar Gómez, Victor Navarro Garces, Pau Abrisqueta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4422.
https://doi.org/10.1182/blood-2024-211078
Published: 2024
Journal Articles

Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study

Ana Marin Niebla, Mariana Bastos-Oreiro, Amanda Isabel Perez, Alba Cabirta Touzón, Fatima De la Cruz Vicente, Marta Canelo, Ana Jiménez Ubieto, Sonia González De Villambrosia, Ana Muntañola, Hugo Daniel Luzardo Henríquez, Eduardo Rios Herranz, Pilar Gómez, Alberto López, Ana Saus Carreres, Alejandro Martín García-Sancho, Ana Garcia Noblejas, Carlos Grande, Pablo Prieto Martinez, Concepción Nicolás, Antonio Gutierrez, Jose-Angel Hernandez Rivas, Blanca Sánchez González, Rosalia Alonso Trillo, Eva Donato, Paola Villafuerte Gutiérrez, Daniel García Belmonte, Silvia Rocio Verdesoto Cozzarelli, Sandra Suarez Ordoñez, Emilia Pardal De La Mano, Lucia Villalon Blanco, Alicia Roldán-Pérez, Eva Gine, Juan-Manuel Sancho, Raul Cordoba, Beatriz De La Cruz, Victor Navarro Garces, Pau Abrisqueta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4403.
https://doi.org/10.1182/blood-2024-209936
Published: 2024
Journal Articles

The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)

Anna Maria Sureda Balarí, Javier Nuñez Cespedes, María José Terol Castera, Francisca Maria Hernandez, Eva Domingo Domenech, Fatima De la Cruz Vicente, Miram Moreno, Elena Amutio, Ana Pilar Gonzalez, Raul Cordoba, Maria Carmen Martinez Munoz, Samuel Romero, Mariana Bastos-Oreiro, Antonia Rodriguez Izquierdo, Javier Briones, Richard Greil, Maria Casanova Espinosa, Araceli Rubio, Irit Avivi, Raquel Del Campo, Pilar Gómez, Theodoros P. Vassilakopoulos, Sandra Bašić-Kinda, Sotiros Papageorgiou, Victor Noriega Concepcion, Jose Sanchez Blanco, Blanca Sánchez-González, Izaskun Zeberio, Ramon García
Journal: Blood
Blood (2024) 144 (Supplement 1): 3049.
https://doi.org/10.1182/blood-2024-211527
Published: 2024
Journal Articles

A Novel Machine-Learning Model to Predict Early Relapse in Mantle Cell Lymphoma (MCL)

Alba Cabirta Touzón, Adrian Mosquera Orgueira, Victor Navarro Garces, Pau Abrisqueta, Rodrigo A Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz Vicente, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 1675.
https://doi.org/10.1182/blood-2023-181628
Published: 2023
Journal Articles

Validation of New International Prognostic Scores, Including Baseline Peripheral Blood Variables, in Patients with Diffuse Large B-Cell Lymphoma and HIV Infection Treated with R-CHOP and Combined Antiretroviral Therapy. Retrospective Study from Spanish Lymphoma Group Geltamo

Maria Huguet, Mireia Morgades, Armando Lopez-Guillermo, Alfredo Rivas-Delgado, Mariana Bastos-Oreiro, Teresa Aldamiz-Echevarría, Antonio Salar, Fátima de la Cruz Vicente, Miguel Alcoceba, Blanca Ferrer Lores, Ana Jimenez-Ubieto, Antonio Gutierrez, Maria Stefania Infante, Sofia Huerga, Pau Abrisqueta, David Cruz, Carlos Montalban, Ana Muntañola Prat, Sonia González de Villambrosia, Míriam Verdú, Juan-Manuel Sancho, Josep-Maria Ribera, José-Tomás Navarro
Journal: Blood
Blood (2021) 138 (Supplement 1): 2497.
https://doi.org/10.1182/blood-2021-148361
Published: 2021
Journal Articles

Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma

Thomas E. Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Dolores Caballero, Ranjana Advani, Raquel de Oña, Ana Marin Niebla, María José Terol, Domingo Domenech Eva, Nawal Bendris, Julie Mackey Ahsan, Mollie Leoni, Francine M. Foss
Journal: Blood
Blood (2021) 138 (Supplement 1): 621.
https://doi.org/10.1182/blood-2021-147279
Published: 2021
Journal Articles

Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Thomas E. Witzig, MD, Lubomir Sokol, MD PhD, Eric D Jacobsen, MD, Won-Seog Kim, MD PhD, Francine M. Foss, MD, Ranjana H. Advani, MD, Jose Maria Roncero Vidal, MD, Ana Marin Niebla, PhD, Antonia Rodriguez Izquierdo, PhD, Raquel De Ona Navarrete, MD, Fátima de la Cruz Vicente, MD, Dolores Caballero, MD, Rufino Mondejar, PhD, Miguel A. Piris, PhD MD, Robert Curry, BA, MBA, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2937.
https://doi.org/10.1182/blood-2018-99-116277
Published: 2018
Journal Articles

Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients

Fátima de la Cruz Vicente, MD, Maria Angeles Domiunguez Muñoz, MD, Estrella Carrillo Cruz, MD, José Francisco Márquez Malaver, Rocio Parody Porras, MD, Jose Francisco Falantes González, MD, Cristina Calderón Cabrera, MD, Olga Pérez López, MD, María Solé Rodríguez, MD, Jose González Campos, MD, María Isabel Montero Cuadrado, MD, María Luz Martino Galiana, MD, Jose Antonio Pérez-Simón, PhD, Ildefonso Espigado, PhD
Journal: Blood
Blood (2014) 124 (21): 3977.
https://doi.org/10.1182/blood.V124.21.3977.3977
Published: 2014
Journal Articles

Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma

Fátima de la Cruz Vicente, Estrella Carrillo Cruz, María Solé Rodríguez, Ana Marín Niebla, Eduardo Ríos Herranz, María Luz Martino Galiana, Jose Falantes González, Isabel Montero Cuadrado, Jose González Campos, Ildefonso Espigado Tocino, Jose A Pérez-Simón
Journal: Blood
Blood (2013) 122 (21): 5087.
https://doi.org/10.1182/blood.V122.21.5087.5087
Published: 2013
Journal Articles

The Role Of 18F-FDG PET/CT For Staging and Response Assessment To Chemotherapy In Marginal Zone Lymphoma.

Marta Ruiz Mercado, Estrella Carrillo Cruz, Fátima de la Cruz Vicente, Víctor A Marín-Oyaga, María Solé Rodríguez, Isabel Borrego-Dorado, Ildefonso Espigado Tocino, Ricardo Vázquez-Albertino, Jose Antonio Pérez-Simón
Journal: Blood
Blood (2013) 122 (21): 4328.
https://doi.org/10.1182/blood.V122.21.4328.4328
Published: 2013